Your exact medication, dose, and compounded formulation are determined by your clinician based on intake responses, eligibility, and state availability
doi: 10.1016/j.cell.2020.02.052 41 HuB.GuoH.ZhouP.ShiZ
Mechanism of Action Comparison IGF-1 LR3 Reduced IGFBP-1, -2, -3 binding affinity Extended circulating half-life (~20-30 hours) Sustained IGF-1 receptor activation Full receptor binding affinity maintained IGF-1 DES Reduced IGFBP binding via truncation Short half-life (~20-30 minutes) Rapid, acute receptor activation Enhanced receptor binding potency reported Research Applications Comparison The choice between IGF-1 LR3 and IGF-1 DES depends on the specific temporal requirements of your research
Timing for Athletes and Active Lifestyles If your life revolves around movement, your timing might look a little different
Hughan Frederick at Glow Anti-Aging Center and Medical Spa in Roswell, Georgia, has a solution that might just change the game for you
Research interest in this peptide centers on its selectivity: it does not appear to elevate IGF-1 levels in studied models, distinguishing it mechanistically from full growth hormone
